CADL (Candel Therapeutics) Gross Profit Margin

Corporate emblem and logo of Candel Therapeutics (CADL)

Candel Therapeutics is an ambitious innovator developing viral immunotherapy to combat oncology. This gross margin chart clearly illustrates the effectiveness of this approach, where 0.00 reflects the latest metric level. The business relies on robotic molecule screening to accelerate testing. Furthermore, drug development is entirely non-cyclical, providing the company with high resilience to any macroeconomic shocks.

CADL: Candel Return on Gross Profit 07/04/2022 - 11/20/2026

Financial and market metric breakdowns for Candel (CADL)

Fundamental valuation:CADL candeltx.com
Flagship merchandise of Candel Therapeutics Inc.

Professional capital evaluates the profile of Candel Therapeutics (CADL) through the lens of the ability of oncolytic platforms to generate high added value supported by big pharma grants. By analyzing gross margin, the investor determines the portion of revenue minus direct production costs, which allows for an assessment of the asset's operational efficiency and fundamental stability amidst market volatility via the dynamics of this curve.

Main competitors

Gross Profit Margin BeiGene Ltd. (ONC)|Return on Gross Profit HALO|Gross Profitability RVMD|Return on Gross Profit AAPG (Ascentage)|Return on Gross Profit cgoncology.com CGON|UroGen Pharma - Return on Gross Profit|Gross Profit Rate BCAX|PSNL - Gross Profitability|Return on Sales by Gross Profit Erasca Oncology ERAS|delcath.com (DCTH) - Gross Profitability|Y-mAbs Therapeutics - Gross Profit Rate|AURA (Aura Biosciences Inc) - Gross Margin|Gross Return on Sales ARAY (Accuray)|Return on Gross Profit SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Gross Profit Margin|Gross Profitability Citius Oncology, Inc. CTOR|HURA - Return on Gross Profit|protaratx.com - Gross Margin|FATE - Gross Margin|WHWK: Gross Margin|TScan Therapeutics (TCRX) - Gross Margin|Gross Profitability Champions Oncology|Gross Profitability XBIT|Gross Margin CVM|Return on Gross Profit OS Therapies Inc. OSTX|Gross Profitability Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Gross Profit Margin|ANL - Gross Profitability|Gross Profit Margin verupharma.com|TPST: Gross Margin|XLO - Return on Sales by Gross Profit|Gross Profitability Renovaro|Gross Margin muraloncology.com|Gross Margin KAPA|Return on Sales by Gross Profit OnKure Therapeutics, Inc.|Gross Margin GDTC (w2.cytomed.sg)|CRIS - Return on Gross Profit|Apollomics - Gross Margin|Tharimmune Corp (THAR) - Return on Gross Profit|ADVB: Gross Margin|Return on Gross Profit Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Gross Margin|Gross Return on Sales SBFM (Sunshine Biopharma)|Gross Profitability Xenetic Bio (XBIO)|Gross Profitability SLRX (Salarius Pharma)|Kitov Pharma - Return on Gross Profit|American Oncology Network (AONC) - Gross Profit Margin|BeiGene - Gross Margin|Checkpoint Therapeutics, Inc. (CKPT) - Return on Gross Profit|ELEV (Elevation Oncology, Inc.) - Return on Gross Profit|iCAD Inc. - Gross Profit Rate|Return on Gross Profit IKNA|Gross Margin notablelabs.com|Return on Gross Profit VIRX (Viracta Therapeutics Inc.)|MOR - Gross Profit Margin|Gross Profitability NAYA Biosciences NAYA|AAPGV - Return on Gross Profit